WVP
RVLP

Worth Venture Partners’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Worth Venture Partners’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-278,654
Closed -$156K – 195
2023
Q2 		$156K Sell
278,654
-44,175
-14% -$39K 0.09% 119
2023
Q1 		$368K Sell
322,829
-133,131
-29% -$160K 0.18% 100
2022
Q4 		$511K Buy
455,960
+270,313
+146% +$431K 0.3% 77
2022
Q3 		$390K Buy
+185,647
New +$361K 0.24% 85

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
TAM
Titleist Asset Management San Antonio, Texas $1.49B AUM 22.27% 1-Year Est. Return

Worth Venture Partners's RVLP Position: Q3 2023 in Review

Worth Venture Partners sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2023, closing a stake of 278,654 shares — an estimated $156K sold.

Worth Venture Partners first reported a position in RVLP in Q3 2022 and held it in 4 quarters. The position peaked at $511K in Q4 2022. 32 funds tracked by Wall St. Rank hold RVLP as of Q3 2023.

  • Worth Venture Partners reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Worth Venture Partners sold 278,654 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2023, an estimated $156K.
  • Worth Venture Partners first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2022 and held it in 4 quarters.
  • Worth Venture Partners's RVL Pharmaceuticals plc Ordinary Shares position peaked at $511K in Q4 2022.
  • 32 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2023.

Based on Worth Venture Partners's 13F filing for Q3 2023, filed 15 Nov 2023.